NCT05486247View on ClinicalTrials.gov

Molecular Characterization of Gliomas Using a Broad Next Generation Sequencing (NGS)Panel

CompletedOBSERVATIONAL

Enrollment

32

Participants

Timeline

Start Date

February 4, 2015

Primary Completion Date

December 1, 2021

Study Completion Date

May 1, 2022

Conditions

Malignant Glioma

All Listed Sponsors

lead

Hellenic Cooperative Oncology Group

OTHER

NCT05486247 - Molecular Characterization of Gliomas Using a Broad Next Generation Sequencing (NGS)Panel | Biotech Hunter | Biotech Hunter